Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 445.0
(5.95%)
JPY 445.0
(5.95%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.53 JPY | 119.65% |
| 2022 | -17.96 JPY | -46.49% |
| 2021 | -12.26 JPY | -6.7% |
| 2020 | -11.49 JPY | -62.52% |
| 2019 | -7.07 JPY | 13.89% |
| 2018 | -8.21 JPY | -246.35% |
| 2017 | 5.61 JPY | -17.62% |
| 2016 | 6.81 JPY | 140.56% |
| 2015 | -16.79 JPY | 7.8% |
| 2014 | -18.21 JPY | 19.21% |
| 2013 | -22.54 JPY | 23.52% |
| 2012 | -29.47 JPY | 1.7% |
| 2011 | -29.98 JPY | 27.88% |
| 2010 | -41.57 JPY | 23.08% |
| 2009 | -54.04 JPY | 3.65% |
| 2008 | -56.09 JPY | 14.2% |
| 2007 | -65.37 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -5.20 JPY | -207.44% |
| 2024 Q2 | -0.35 JPY | 93.27% |
| 2023 Q1 | 0.34 JPY | 113.33% |
| 2023 Q2 | -0.63 JPY | -285.29% |
| 2023 FY | - JPY | 119.65% |
| 2023 Q3 | -1.03 JPY | -63.49% |
| 2023 Q4 | 4.84 JPY | 569.9% |
| 2022 FY | - JPY | -46.49% |
| 2022 Q1 | -6.60 JPY | -70.54% |
| 2022 Q2 | -3.77 JPY | 42.88% |
| 2022 Q3 | -5.03 JPY | -33.42% |
| 2022 Q4 | -2.55 JPY | 49.3% |
| 2021 Q2 | -3.40 JPY | -6.58% |
| 2021 FY | - JPY | -6.7% |
| 2021 Q1 | -3.19 JPY | -129.5% |
| 2021 Q3 | -1.80 JPY | 47.06% |
| 2021 Q4 | -3.87 JPY | -115.0% |
| 2020 Q3 | -3.39 JPY | -41.25% |
| 2020 Q2 | -2.40 JPY | 44.32% |
| 2020 Q1 | -4.31 JPY | -331.72% |
| 2020 FY | - JPY | -62.52% |
| 2020 Q4 | -1.39 JPY | 59.0% |
| 2019 FY | - JPY | 13.89% |
| 2019 Q3 | -2.26 JPY | -6.1% |
| 2019 Q2 | -2.13 JPY | 53.08% |
| 2019 Q1 | -4.54 JPY | -221.39% |
| 2019 Q4 | 1.86 JPY | 182.3% |
| 2018 Q3 | -1.73 JPY | -383.61% |
| 2018 FY | - JPY | -246.35% |
| 2018 Q1 | -10.84 JPY | -462.54% |
| 2018 Q2 | 0.61 JPY | 105.63% |
| 2018 Q4 | 3.74 JPY | 316.18% |
| 2017 Q3 | 0.97 JPY | -37.82% |
| 2017 Q2 | 1.56 JPY | 1633.33% |
| 2017 FY | - JPY | -17.62% |
| 2017 Q1 | 0.09 JPY | -99.24% |
| 2017 Q4 | 2.99 JPY | 208.25% |
| 2016 FY | - JPY | 140.56% |
| 2016 Q4 | 11.83 JPY | 1345.26% |
| 2016 Q3 | -0.95 JPY | 7.77% |
| 2016 Q2 | -1.03 JPY | 66.01% |
| 2016 Q1 | -3.03 JPY | -46.38% |
| 2015 Q2 | -5.03 JPY | 13.57% |
| 2015 Q3 | -6.87 JPY | -36.58% |
| 2015 Q4 | -2.07 JPY | 69.87% |
| 2015 FY | - JPY | 7.8% |
| 2015 Q1 | -5.82 JPY | -356.39% |
| 2014 Q2 | -8.60 JPY | -48.02% |
| 2014 Q4 | 2.27 JPY | 137.34% |
| 2014 FY | - JPY | 19.21% |
| 2014 Q1 | -5.81 JPY | -183.41% |
| 2014 Q3 | -6.08 JPY | 29.3% |
| 2013 Q3 | -6.96 JPY | 5.82% |
| 2013 Q1 | -6.15 JPY | 8.07% |
| 2013 FY | - JPY | 23.52% |
| 2013 Q4 | -2.05 JPY | 70.55% |
| 2013 Q2 | -7.39 JPY | -20.16% |
| 2012 Q1 | -8.39 JPY | -24.3% |
| 2012 FY | - JPY | 1.7% |
| 2012 Q4 | -6.69 JPY | 13.0% |
| 2012 Q3 | -7.69 JPY | -14.61% |
| 2012 Q2 | -6.71 JPY | 20.02% |
| 2011 FY | - JPY | 27.88% |
| 2011 Q1 | -7.32 JPY | 0.95% |
| 2011 Q4 | -6.75 JPY | 13.35% |
| 2011 Q3 | -7.79 JPY | 4.06% |
| 2011 Q2 | -8.12 JPY | -10.93% |
| 2010 Q1 | -13.85 JPY | -9.31% |
| 2010 Q3 | -8.55 JPY | 33.93% |
| 2010 Q4 | -7.39 JPY | 13.57% |
| 2010 Q2 | -12.94 JPY | 6.57% |
| 2010 FY | - JPY | 23.08% |
| 2009 FY | - JPY | 3.65% |
| 2009 Q3 | -13.07 JPY | 1.66% |
| 2009 Q2 | -13.29 JPY | 11.58% |
| 2009 Q1 | -15.03 JPY | -15.35% |
| 2009 Q4 | -12.67 JPY | 3.06% |
| 2008 FY | - JPY | 14.2% |
| 2008 Q3 | -13.96 JPY | -0.22% |
| 2008 Q2 | -13.93 JPY | 8.23% |
| 2008 Q1 | -15.18 JPY | 0.0% |
| 2008 Q4 | -13.03 JPY | 6.66% |
| 2007 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 96.171% |
| PRISM BioLab Co.,LTD | -14.90 JPY | 123.691% |
| GNI Group Ltd. | 169.50 JPY | 97.917% |
| Linical Co., Ltd. | 14.98 JPY | 76.435% |
| Trans Genic Inc. | 0.24 JPY | -1370.833% |
| MEDINET Co., Ltd. | -6.65 JPY | 153.083% |
| Soiken Holdings Inc. | -25.32 JPY | 113.942% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | 77.182% |
| AnGes, Inc. | -39.29 JPY | 108.984% |
| OncoTherapy Science, Inc. | -6.05 JPY | 158.347% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 104.05% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 82.394% |
| NanoCarrier Co., Ltd. | -11.10 JPY | 131.802% |
| Carna Biosciences, Inc. | -68.62 JPY | 105.144% |
| CanBas Co., Ltd. | -67.87 JPY | 105.201% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | 113.811% |
| RaQualia Pharma Inc. | -14.98 JPY | 123.565% |
| Chiome Bioscience Inc. | -24.62 JPY | 114.338% |
| Kidswell Bio Corporation | -40.23 JPY | 108.775% |
| PeptiDream Inc. | 23.41 JPY | 84.921% |
| Oncolys BioPharma Inc. | -108.92 JPY | 103.241% |
| Ribomic Inc. | -28.70 JPY | 112.3% |
| SanBio Company Limited | -40.48 JPY | 108.72% |
| Healios K.K. | -56.22 JPY | 106.279% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | 119.385% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | 113.177% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 101.776% |
| StemRIM | -32.98 JPY | 110.703% |
| CellSource Co., Ltd. | 48.88 JPY | 92.778% |
| FunPep Company Limited | -39.63 JPY | 108.907% |
| Kringle Pharma, Inc. | -158.46 JPY | 102.228% |
| Stella Pharma Corporation | -24.66 JPY | 114.315% |
| TMS Co., Ltd. | -26.02 JPY | 113.566% |
| Noile-Immune Biotech Inc. | -27.25 JPY | 112.954% |
| Cuorips Inc. | -85.87 JPY | 104.111% |
| K Pharma,Inc. | 22.43 JPY | 84.262% |
| Takara Bio Inc. | 12.29 JPY | 71.277% |
| ReproCELL Incorporated | -0.37 JPY | 1054.054% |
| PhoenixBio Co., Ltd. | 6.88 JPY | 48.692% |
| StemCell Institute Inc. | 30.25 JPY | 88.331% |
| CellSeed Inc. | -29.43 JPY | 111.995% |